Whole-body cryotherapy for patients with fibromyalgia syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035251

Enrollment

Registered

2024-10-14

Start date

2024-10-14

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M79.7

Interventions

Group 1: Water aerobics and whole-body cryotherapy Group 2: Only water aerobics

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - reliably diagnosed fibromyalgia syndrome according to American College of Rheumatology criteria (Wolfe et al., 2010), - Age between 18 and 80 years, - Tolerance to whole-body cryotherapy, - BMI < 40 kg/m2, - blood pressure < 160/90 mmHg, - good general health

Exclusion criteria

Exclusion criteria: Cardiovascular system: - PAD (all stages), - Thrombosis (within 160 mmHg -Bronchial asthma or severe chronic obstructive pulmonary disease Electronic implants - Pacemaker, defibrillator, neurostimulators - Poor general condition, General: - Acute infection (respiratory tract, urinary tract, herpes) - Severe neurological-psychiatric illness (epilepsy, dementia, psychosis, substance abuse disorder/acute withdrawal, claustrophobia), - pregnancy - unstable insulin-dependent diabetes mellitus, tendency to hypoglycaemia, circulatory problems, fainting spells, - Known cold agglutinins or cold allergy, patients who have experienced significant side effects during cryotherapy - Known (relevant) coagulation disorders - Hyperreactive bronchial system - Wound healing disorders, open wounds - Non-removable metal on the body - BMI40 - Surgery < 6 weeks ago - Exercise therapy performed in parallel, - Patients with severe hearing or visual impairment, - severe headaches, - tumour diseases/chemotherapy, - Stoma care (enterostomy, tracheostomy, urostomy, port) - Polyneuropathies, hyperhidrosis

Design outcomes

Primary

Measure	Time frame
Fibromyalgia Impact Questionnaire (0-100 Points)	—

Secondary

Measure	Time frame
Questionnaires: - SF-36 Questionnaire (0-100 Points) Functional targets: Aerobic endurance: - 6 minute walk test (6MWT) Mobility: - Sit and reach test Balance: - One leg stand (Flamingo Test) Strength: - Grip strength (hand dynamometer) - 30-second sit-to-stand test	—

Countries

Germany

Contacts

Public ContactJens Adermann

Klinik für Manuelle Therapie Hamm

Jens.Adermann@KMT-Hamm.de+49 2381 9860

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026